Compare Healthpeak Properties Inc. Common Stock (DOC) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Healthpeak Properties Inc. Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Healthpeak Properties Inc. Common Stock trades at $18.55 (market cap $12.87B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 4.5× Healthpeak Properties Inc. Common Stock's market cap, and Healthpeak Properties Inc. Common Stock pays the higher dividend (6.54%). Which is the better fit depends on your goals — on Pluang, investors hold Healthpeak Properties Inc. Common Stock for 0 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| DOC | TAK | |
|---|---|---|
Market Cap | $12.87B | $58.16B |
Volume | 5,134,919 | 2,467,530 |
Sector | Real Estate | Health |
52-Week High | $22.82 | $19.05 |
52-Week Low | $15.78 | $13.23 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $21.56B | $86.04B |
Dividend Yield | 6.54% | 3.36% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Healthpeak Properties Inc. Common Stock
Healthpeak Properties is a healthcare real estate investment trust in the United States. It owns, operates, and develops outpatient medical, laboratory, and senior housing properties.
Read more on DOC →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
